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The purpose of these studies was to examine the eﬀects of electroacupuncture (EA) Zusanli (ST36) on release of nitric oxide
(NO) in the gracile nucleus (GN) and determine if functional neuropathic changes were modiﬁed by EA ST36-induced NO in
the nucleus in Zucker diabetic fatty (ZDF) rats. The foot withdrawal responses to mechanical, thermal and cold stimuli were
measured before and after EA stimulation. A microdialysis probe was implanted in the GN and dialysate samples were collected
20 min before, during and after EA ST36. Total nitrate and nitrite (NO
−
x ) concentrations in the samples were quantiﬁed by using
chemiluminescence. The baseline dialysate NO
−
x concentrations in the GN were decreased in ZDF rats compared to lean control
(LC)rats(P<. 05).I nZDFrats,dialysat eNO
−
x releases intheGN were markedly increasedduring EA ST36,whereasinLCrats,the
releases were moderately enhanced at 20–40min after EA ST36. The withdrawal latencies to mechanical, cold and thermal stimuli
were signiﬁcantly improved 20min after EA ST36 both in LC and ZDF rats, but not altered by non-acupoint stimulation. The
withdrawallatencies to EA ST36were further potentiated by 3-morpholinyl-sydnoneimineandinhibited by NG-Propyl-l-arginine
infused intothe GN in ZDF rats(P<. 05).These results showthatEA ST36increases NO release in theGN, andNO inthe nucleus
modiﬁeswithdrawallatencies to mechanical,cold, andthermalnociception stimuli.DatasuggestthatEAST36induces NO release
in the GN, which contributes to improvement of sensory neuropathies in rats.
1.Introduction
Sensory neuropathy is a frequent complication of diabetes
that is accompanied with pain, paresthesia and reduced
temperature and vibration perception thresholds [1, 2].
Previous studies using the Zucker diabetic fatty (ZDF)
rat model have shown that nerve conduction velocity is
decreased [3–5] and pain/pressure thresholds are abnormal
at 11–13 weeks of age in diabetic versus lean rats [6–
8]. The treatment of sensory neuropathy of diabetes has
become a challenge especially in the long-term manage-
ment of neuropathic pain [9, 10]. Consequently, diverse
treatments are used for diabetic neuropathy, including non-
invasive drug therapies (antidepressants, antiepileptic drugs
and membrane stabilizing drugs), invasive therapies (nerve
blocks, ablative surgery) and alternative therapies (e.g.,
acupuncture and herbal) [10–13]. No consistently eﬀective
treatment for diabetic neuropathy is available and patients
are forced to struggle with medications that provide only
partial relief [9, 14]. Acupuncture and electroacupuncture
(EA) is widely applied to treat various diseases including
diabetic neuropathies and is becoming more recognized
worldwide. Several clinical studies suggest that acupuncture
decreases neuropathy-associated pain and improves nerve
sensation [14–16]. Although acupuncture is a safe and
eﬀective therapy for improvement in symptoms of sensory
neuropathy, the number of long-term pain relief is small and
the therapeutic eﬀects need to be improved [14, 15].
Studies on the mechanisms of action have revealed that
endogenous opioid peptides in the central nervous system
play an essential role in mediating the analgesic eﬀect of
EA [17]. Chang et al. [18] suggest that EA stimulation at
the Zhongwan acupoint induces secretion of endogenous
beta-endorphin that reduces plasma glucose concentration
in an insulin-dependent manner. Another opinion shows
that nitric oxide(NO)mediates acupuncturesignals through2 Evidence-Based Complementary and Alternative Medicine
the dorsal medulla-thalamic pathways [19], as illustrated in
Figure 1. The gracile nucleus (GN) is the site in the dorsal
medulla that receives primary sensory aﬀerents projecting
from the hindlimb [20, 21]. A number of recent studies have
suggested that the GN is an important area responsible for
sensory/pain regulation [22–24]. Previous studies from this
laboratory have demonstrated that expression of neuronal
NO synthase (nNOS) in the GN is induced by sciatic nerve
injury and EAstimulation ofhindlimb acupointsin rats[25–
27]. In SD rats, EA stimulation of Zusanli (ST36), a vital
acupointontheleg,decreasedarterial bloodpressureandthe
eﬀects were facilitated by a microinjection of an exogenous
NO donor in the GN [28]. NO is one of the most important
messenger molecules produced in many cell types, including
the neurons in the central nervous system (CNS) [29, 30].
It has been demonstrated that neuronal NO generation is
impaired and is associated with hyperalgesia in diabetic rats
[30,31].However,themechanisms andactionsofNOrelease
responsiblefortheanalgesiceﬀectsofEAarenotunderstood.
The purpose of this study is to examine the hypothesis
that there is a neural circuit related to transduction
of somatosensory information and EA ST36 in the
aﬀerent inputs-dorsal medulla-thalamic-eﬀerent pathways
(Figure 1). EA stimulation of ST36 induces NO release in
the GN resulting in inhibition of heat, cold and mechanical
sensitivities through the dorsal funiculus tract brain circuit.
The relationship between medullar NO releases and sensory
neuropathies was determined by quantiﬁcation of dialysate
NOmetabolitesintheGNandthefootwithdrawal responses
to mechanical, thermal and cold stimuli in ZDF compared
to age-matched lean control (LC) rats. The eﬀects of EA
ST36 on NO release in the GN and improvements in
hyperalgesia to thermal, cold and tactile stimulations were
quantiﬁed before and after EA stimulation of ST36 and
non-acupoint in ZDF rats. In order to investigate the direct
eﬀects of NO presence in the GN on sensory neuropathic
changes, withdrawal latencies to mechanical, thermal and
cold stimuli were measured before and after microinfusion
of 3-morpholinyl-sydnoneimine (SIN-1, an exogenous NO
donor)orNG-Propyl-l-arginine (NPLA,a selective inhibitor
of neuronal NO synthesis) into the GN in ZDF rats.
2.Methods
2.1. Experimental Animals. Experiments were performed on
ZDF rats (11–12 weeks) and age-matched LC rats (Genetic
Models, Inc., Indianapolis). ZDF rats were fed Purina 5008
(16.7 kcal% of fat) diet chow [7]. All rats were given
continuous access to food and water. The protocol was
approved by the Harbor-UCLA Animal Use Committee
and was in accord with the American Association for the
Accreditation of Laboratory Animal Care (AAALAC) and
NationalInstitutesofHealth(NIH)guidelines.Animals were
maintained on a 12-h light-dark cycle in temperature and
humidity-controlled rooms. The body weight and blood
glucoseconcentrationswere assessed before and attheendof
thetreatments. The concentrationofbloodglucosewasmea-
sured with a glucometer(Elite, Bayer), and the blood sample
was obtained by performing a small incision at the tail end.
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Figure 1: A schematic model of signal transduction of somatosen-
sory information and acupuncture signals in the dorsal funiculus
tract brain circuit. Acupuncture stimulation of hindlimb acupoint,
ST36, induces NO release in the GN, which causes NO-mediated
inhibition of mechanical, cold and thermal stimuli through
aﬀerents-dorsal medulla-thalamic pathways.
2.2. Measurements of Tactile Withdrawal Latency. The paw
withdraw latency to mechanical nociceptive stimulation was
elicited by applying a von Frey ﬁlament (Semmes-Weinstein
Von Frey Aesthesiometer Kit, Cimerio, Italy) as previously
described [32, 33]. The rats were placed in a cage with wire
mesh ﬂoor and allowed to habituate for 15 min before each
measurement. A paw withdrawal response was elicited by
applying a 29g von Frey ﬁlament on the planter surface of
the ipsilateral hind paw. A positive response was indicated
by a sharp withdrawal of the paw. The force applied to elicit
a reﬂex removal of the ipsilateral hind paw was monitored.
The authors chose a 29g von Frey ﬁlament according to
previous report [33] and our preliminary study revealed
that more than half of applying a 29g von Frey ﬁlament
induce withdrawal responses in the LC rats. The withdrawal
latencies were expressed in seconds, which was the time the
rat withdrew its hind foot in reaction to the stimulation. The
inter-stimulus interval is 5min. The decimal was 0.1s, and
four latencies were recorded and averaged for the ipsilateral
hind paw in each test session.
2.3.MeasurementsofThermalandColdWithdrawalLatencies.
Withdrawal latencies of the hind foot to cold and thermal
stimuli were tested using a plate kept at 4◦Ca n d5 2 ◦C,
respectively. The plate tool was applied to the dorsal surface
of the hind foot once in each trial, for four trials [32–35].
The withdrawal latencies were expressed in seconds, which
was the time the rat withdraw its hind foot in reaction to
the stimulation. The heat or cold source created a constant
stimulus until the rats voluntarily withdrew their paw. The
cut time was 10s to avoid injury to the skin. The decimal
was0.1sand fourmeasurementswere averagedforeach paw.
Testing was repeated every 5min for a total of four trials in
each test session.
2.4. EA Stimulation. T h er a t si nt h ee x p e r i m e n t sw e r ep l a c e d
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cylinder. EA stimulation was bilaterally applied to the points
of Zusanli (ST36) at the depression below the knee from the
anteriorcrestof thetibia[28,36].Asacontrolforthespeciﬁc
acupoint eﬀects, stimulation was also applied to the “non-
acupoints” located nearby ST36 in the hamstring muscles as
described [28, 37]. The needle electrodes (27-gauge sharp-
ened stainless-steel insect pins) were inserted percutaneously
into a depth of 4mm at the points of ST36 as previously
described [28, 36]. EA stimulation was performed using a
battery-powered stimulator (Skylark Electro-stimulator SK-
700B) connected to each pair of needle electrodes. Biphasic
pulse electrical stimuli were applied to the acupoints using
a current 1.0mA with duration of 1.0ms for 20min in
conscious rats. Diﬀerent frequencies (3, 10, 30 and 60Hz) of
EAwereapplieddailyatST36oratnon-acupointinZDFand
LC rats for 5 days. The mechanical tolerance and withdrawal
threshold of the foot in responses to EA ST36 were measured
at 10-min intervals before, and 10 and 30min after each
phase of EA stimulation.
2.5. Microdialysis in the GN. The objective was to determine
whether NO releases paralleled changes in mechanical
threshold and latencies offoot withdrawal to noxious heat or
coldstimulationinducedbyEAST36.Theratswereplacedin
astereotaxicapparatuswiththeheadﬂexedat45◦ tofacilitate
exposure of the obex under anesthesia with ketamine
(100mgkg−1) and xylazine (13mgkg−1, i.p.). A heating pad
was used to prevent heat loss and maintain body temper-
ature at 37.5◦C. A CMA 12 microdialysis siliconized guide
(CMA/Microdialysis, North Chelmsford, MA, USA) was
implanted into the GN using previously described methods
[38, 39]. The guide cannula was secured in place with dental
cement. The animals were allowed to recover. A microdial-
ysis probe (CMA/11, the cuprophane dialysis membrane,
length 1mm, diameter 0.24mm, molecular cut-oﬀ 6kDa;
CMA/Microdialysis, North Chelmsford, MA, USA) was
inserted into the GN (1mm under the surface) through the
cannula 48h after surgery. Artiﬁcial cerebrospinal ﬂuid (pH
adjusted to 7.4 CMA/Microdialysis) was infused at a rate
of 3µlmin −1. The inlet/outlet dialysis capillaries were con-
nected to polyethylene tubing. The inlet tube was connected
to a 50µl microsyringe driven by the CAM 102 microdialysis
pump. The outlet was positioned in a collecting tube set in
the ice
Toverifythesiteofmicrodialysis, 2%pontaminesky blue
was injected into the GN after all the experiment procedures
had been done. The rats were deeply anesthetized; the
brains were removed and stored in a 10% paraformaldehyde
solution.The frozen brain tissuewassectioned in thecoronal
plane (40µm). The site of the dialysis tube was veriﬁed
histologically in the brain sections after cresyl violet staining
[40]. The blue stained area in the brainstem containing the
GN was countered under the light microscope. The results
from the animals with injection diﬀusing out of the GN were
excluded from statistic data.
2.5.1. Biochemical Analysis of NO
−
x Concentrations. The con-
centrations ofNO
−
x (NO
−
2 and NO
−
3 )in thedialysatesamples
were measured using an ozone phase chemiluminescence
(NOA280i, GE Analytical Instruments, Boulder, CO, USA)
as described [38, 41]. The measurement was conducted in
a blinded manner. Brieﬂy, 5µl dialysate samples (fresh or
previously frozen) were reduced using a Vanadium (III)/HCl
solution. The nitrate calibration curve was established using
known concentrations of NaNO3 dissolved in the sterile
nitrogen-free water. The total amount of NO
−
3 in each
dialysate sample was calculated by integration of the signal
peaks using the nitrate calibration curve. All samples were
measured in duplicate. The presence of (NO
−
2 )i no u r
dialysatesampleswasclosetothewaterbasallevel.Therefore,
the ﬁnal NO
−
x concentration in the dialysate was expressed
in micromolars with no allowance made for NO
−
2 .T h e
minimum sensitivity level of NO amount is 1.0pmol.
2.6. Experimental Protocol. T h er a t sw e r ed i v i d e di n t ot w o
groups (n = 20), LC rats group (n = 10) and ZDF rats group
(n = 10). In each group, EA stimulation of ST36 and non-
acupointwasperformed using 1.0mA,durationof1.0msfor
20min. These stimulationparameters with 3,10, 30 or60Hz
were randomly conducted at day 1, 2, 3 and 4, respectively.
Measurements of mechanical, thermal and cold hyperalgesia
were conducted twice at 20-min intervals before (averagedto
obtaina controlvalue) and at 20, 40,60, 80, 100and 120min
after EA stimulation in conscious rats.
On the ﬁfth day, EA stimulation was performed using
10Hz based on the results from Day 1 to 4 tests. Artiﬁcial
cerebral spinal ﬂuid was perfused in the unilateral side of
the GN. The dialysate samples were collected during EA and
every20minafterEAforatotalof120minformeasurements
of NO
−
x concentrations. After a 20-min period of dialysis
equilibration, 20-min dialysate samples were collected dur-
ing each subsequent perfusion condition. In each treatment
group, the dialysate samples were collected at two 20-min
intervals before stimulation (averaged to obtain a control
value), 20-min interval during EA stimulation and four 20-
min intervals after the stimulation. In another group of
rats, SIN-I (10µM) or NPLA (100µM) was dissolved in
the perfusion ﬂuid and infused via retrograde microdialysis
into the nucleus for 20min. Then the measurements of
mechanical, thermal and cold hyperalgesia were conducted
before and after EA ST36 or EA non-point.
At the end of the experiment, the probe was checked for
the presence of air bubbles, and the position in the GN was
veriﬁed by microscopy of perfusion-ﬁxed sections [39, 40].
Following completion of the experiments, the rats were
sacriﬁced by sodium pentobarbital (150mgkg−1, i.v.). The
brains were removed and stored in a 10% paraformaldehyde
solution. The site of microdialysis was veriﬁed histologically
on coronal and sagittal brain sections after crystal violet
staining. Serial coronal sections of 40-µmt h i c k n e s sw e r e
made using a freezing microtome (Microm-HM400). Histo-
logical veriﬁcation was carried out and referenced to the rat
brain in stereotaxic coordinates [42]. The microdialysis area
in the brainstem containing the GN was examined under the
lightmicroscope.Theresultsfromtheanimalswithinfusions
diﬀusing out of the nucleus and incorrect infusion site were
excluded from statistic data.4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Withdrawal latencies to mechanical (a), cold (b) and thermal stimuli (c) on foot following EA stimulation of ST36 in conscious
ZDF rats compared to LC rats. Values were expressed as mean ± SEM (n = 10). ∗P<. 05 versus non-point control, #P<. 05 versus LC rats.
2.7. Chemicals. The chemicals used in these experiments
were NPLA (Calbilchem) and SIN-1 (Tocris).
2.8. Statistical Analysis. The results were expressed as mean
± standard error mean (SEM). LC and ZDF rats were
used for each deﬁned group. Analysis of variance (one-way
ANOVA and Turkey HSD) and Student’s t-test (unpaired)
were used to analyze signiﬁcant diﬀerence using software
SSPS11.5 (SSPSInc., Chicago, IL, USA).A P-value< .05 was
considered signiﬁcant.
3.Results
Of the 20 experimental rats, the body weights were of
minimal variation, 509.1 ± 46.3g in ZDF rats versus 346.2
± 9.3g in LC rats (P<. 01, n = 10/group). Blood glucose
was markedly elevated (P<. 001) in ZDF rats 301.3 ± 25.1
versus LC rats 122.1 ± 4.3mg/dl−1.
3.1. Behavior Determination of Neuropathies In Vivo. The
withdrawal latencies to the application of mechanical,
thermal or cold stimulation were examined in ZDF rats
compared to age-matched LC rats (n = 10 in each group).
The baseline withdrawal latencies to mechanical stimulation
on the foot were signiﬁcantly decreased (P<. 05) in ZDF
versus LC rats (Figure 2(a)). The withdrawal latenciesto cold
stimuli of ZDF rats were also reduced compared to LC rats
(P<. 05) (Figure 2(b)). The withdrawal latencies to thermal
stimuli of ZDF rats were markedly reduced compared to LC
rats (P<. 05), as shown in Figure 2(c).
The withdrawal latencies to application of mechanical
or cold stimulation were increased 20min after EA ST36
in both LC and ZDF rats (P<. 05), as shown in Figures
2(a) and 2(b). The values of the withdrawal latencies to
thermal stimuli tended to be high 20min after EA ST36 in
LC rats compared to control, but this increase fell short of
statistical signiﬁcance. The withdrawal latencies to thermal
stimuli were signiﬁcantly increased 20min after EA ST36 in
ZDF rats (Figure 2(c)). One-way ANOVA and Turkey HSD
analysis indicatedthattherewere nosigniﬁcantdiﬀerencesof
withdrawal latencies to cold and thermal stimuli in ZDF ver-
susLCratsafterEAST36.Incontrast,EAstimulationofnon-
acupoint did not induce detectable changes in withdrawal
latencies to mechanical, cold and thermal stimuli in LC rats.Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Percentage changes in withdrawal latencies to mechanical (a), cold (b) and thermal stimuli (c) induced by diﬀerent frequency
EA ST36 in conscious LC rats and ZDF rats. Parameters of stimulation: 6V, 1ms pulse duration, 3, 10, 30 and 60Hz for 20min. ANOVA
revealed signiﬁcant diﬀerences of 10 and 30Hz compared with 3 and 60Hz EA stimulation (P<. 05, n = 10/group).
3.2. Withdrawal Latencies to EA Stimulation of ST36 with
Diﬀerent Frequency. The eﬀects of diﬀerent frequencies on
sensoryneuropathicchangeswerestudiedfollowingEAST36
using 3, 10, 30 and 60Hz in ZDF versus LC rats. Withdrawal
latencies to mechanical, thermal or cold stimulation were
continually observed for 3 days and the averaged numbers
were used to serve as control values before EA. Following
EA ST36 with constant voltage and duration in LC rats,
the withdrawal latency responses were enhanced on the
frequency from 3 to 30Hz, but did not increase further
at 60Hz (Figure 3). In ZDF rats, the values of increases
in withdrawal latency responses to 10 and 30Hz EA ST36
were better than those induced by 3Hz and 60Hz, as shown
in Figure 3.H o w e v e r ,t h ew i t h d r a w a ll a t e n c i e st oE AS T 3 6
were signiﬁcantly attenuated in 60Hz compared with 10 and
30Hz EAs in both ZDF and LC rats (P<. 05). There was no
statistically signiﬁcant diﬀerence between 10 and 30Hz EA
ST36 (Figure 3).
3.3. Baseline of the Dialysate NO
−
x Concentrations in the GN
of LC Rats and ZDF Rats. NO metabolites, total nitrate and
nitrite (NO
−
x ) concentrations in the dialysate samples were
collected at 20-min intervals obtaining at 20, 40, 60, 80, 100
and 120min in ZDF and LC rats (Figure 4). In ZDF rats,
baseline dialysate NO
−
x releases in the GN were signiﬁcantly
lower than those in LC rats during the ﬁrst and second 20-
min intervals of dialysis (P<. 05). The levels of dialysate
NO
−
x concentrationsat40–60,60–80and80–100mininZDF
rats suggested a slight reduction compared to LC rats. There
were similar dialysate NO
−
x concentrations at 100–120min
between ZDF rats and LC rats, as shown in Figure 4.I n
LC rats, baseline dialysate NO
−
x concentration during the
ﬁrst 20-min interval of dialysis was much higher than those
in ZDF rats (Figure 4). Dialysate NO
−
x concentrations were
markedly reduced at 40–120min dialysis compared to 0–40
dialysis in LC rats (P<. 0 5 ) .H o w e v e r ,t h e r ew e r em o d e r a t e
reductions of dialysate NO
−
x concentrations at 40–120min6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: The time intervals of dialysate nitrite plus nitrate (NO
−
x )
concentrationsin theGN inZDF ratsversusLCrats.DialysateNO
−
x
from perfusion periods was analyzed as follows: 0–20, 20–40, 40–
60, 60–80, 80–100 and 100–120min. Each point represents mean
± SEM (n = 10). ∗P<. 05 versus LC rats. There was a signiﬁcant
diﬀerence of the dialysate NO
−
x concentrations between ZDF rats
and LC rats in 0–20 and 20–40min (P<. 05).
dialysis compared to 0–20 dialysis in ZDF rats, as shown in
Figure 4.
3.4. Responses of Dialysate NO
−
x Releases in the GN to EA
ST36. Figure 5(a) shows dialysate NO
−
x concentrations in
the GN before, during and 20, 40, 60 and 80min after
EA stimulation of ST36 and non-acupoint in ZDF and LC
r a t s .T h e r ew a sn os i g n i ﬁ c a n tc h a n g ei nN O
−
x concentrations
following EA non-acupoint in both ZDF and LC groups
(Figure 5(a)). However, NO
−
x concentrations in the GN of
ZDF rats were markedly increased at 20–40min during EA
ST36 (P<. 05, n = 8). In LC rats with EA ST36, dialysate
NO
−
x concentrations in the GN were marginally increased
20 min (P = .086) and signiﬁcantly increased 40 min after
EA (P<. 05), as shown in Figure 5(a).D i a l y s a t eN O
−
x
concentrations in the GN were signiﬁcantly increased during
EA ST36 in both LC and ZDF dialysis groups compared to
the control without EA groups (Figure 5(a)).
The maximum changes in dialysate NO
−
x collected from
the GN induced by EA ST36 in LC rats and ZDF rats were
compared with their control groups without the stimulation
(Figure 5(b)). The EA stimulation was given at ST36 (n = 8)
or non-point (n = 8) for 20min. The dialysate was collected
in the GN every 20min for a period of 2h (total of six
collections). The maximum NO
−
x change for each subject
was determined by the highest NO
−
x amount during the 2h
after EA stimulation. The change of the NO
−
x concentration
(µM) was calculated by comparing the diﬀerence of the
highest NO value in EA groups and the basal NO
−
x value
at that time in control groups. In LC rats, EA stimulation
of non-acupoint did not induce detectable changes in
maximum dialysate NO
−
x concentration (Figure 5(b)). There
were statistically signiﬁcant diﬀerences in the maximum
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Figure 5: Time response curves of changes in dialysate NO
−
x
concentrations in the GN following EA stimulation of ST36 and
non-acupoint in ZDF and LC rats during 120min (a). Maximum
changes in dialysate NO
−
x releases from theGN induced by EA ST36
inLCratsandZDF ratswere calculated by comparingthediﬀerence
o ft h eh i g h e s tN Ov a l u ei nE Ag r o u p sa n dt h eb a s a lN O
−
x value at
that time in control groups without the stimulation (b). Each point
represents mean ± SEM (n = 10).
change of NO
−
x releases between EA ST36 and control group
without EA in LC rats (P<. 05). In ZDF rats, maximum
change in NO
−
x release was markedly increased in the EA
ST36 group compared to control rats without EA (P<. 05),
as shown in Figure 5(b).
3.5. Eﬀects of an Exogenous NO Donor and an Inhibitor of
Neuronal NO Synthesis in the GN on Withdrawal LatenciesEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: Changes in withdrawal responses of latency to mechanical, cold and thermal stimuli in ZDF rats following EA ST36 or non-
acupointwithorwithoutmicroinfusionSIN1intoGN. Valueswere expressed asmean ±SEM(n = 10).One-wayANOVAanalysisindicated
that there were signiﬁcant diﬀerences between SIN1 infusion alone and SIN1 infusion plus EA ST36, and between EA ST36 and EA non-
point followingSIN1 infusion.Withdrawallatencies to mechanical stimuli(a) and thermal stimuli(c) were signiﬁcantlyincreased at 20 min
a f t e rE AS T 3 6p l u sS I N 1( P<. 05). Withdrawal latencies to cold stimuli were increased at 40min after EA ST36 (b).
to EA ST36. Withdrawal latencies to mechanical, cold and
thermal stimuli in ZDF rats were examined following EA
ST36 or non-acupoint with or without microinfusion SIN1,
an exogenous NO donor, into the GN. Figure 6 shows that
withdrawal latencies to mechanical stimuli (Figure 6(a)),
cold stimuli (Figure 6(b)) and thermal stimuli (Figure 6(c))
were moderately enhanced at 20min following SIN1 infu-
sion alone in ZDF rats. However, withdrawal latencies
to mechanic, cold and thermal stimuli were markedly
increased by SIN1 infusion plus EA ST36 compare to SIN1
infusion alone. Withdrawal latencies to mechanical stimuli
(Figure 6(a)) and thermal stimuli (Figure 6(c))w e r es i g n i ﬁ -
cantly increased by SIN1 infusion plus EA ST36 compare to
EAST36alone at20min afterEAST36,asshown inFigure 6.
For the withdrawal latencies to cold stimuli (Figure 6(b)),
thereweresigniﬁcant diﬀerencesbetweenEAST36plusSIN1
infusion and EA ST36 alone at 40min after EA ST36 (P<
.05). One-way ANOVA analysis indicated that the changes
in withdrawal latencies were signiﬁcant diﬀerences between
SIN1 infusion alone and SIN1 infusion plus EA ST36, and
between EAST36andEAnon-point following SIN1infusion
(Figure 6).
Withdrawal latencies to mechanical, cold and thermal
stimuli in ZDF rats were tested before and after NPLA
microinfusion, an selective inhibitor of neuronal NO syn-
thesis into the GN. Figure 7 shows that withdrawal laten-
cies to mechanical stimuli (Figure 7(a)), cold stimuli
(Figure 7(b)) and thermal stimuli (Figure 7(c))w e r es i g n i f -
icantly decreased after microinfusion of NPLA into the GN.
Following microinfusion of NPLA into the GN, withdrawal8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Withdrawal latencies to mechanical (a), cold (b), and thermal stimuli(c) on foot in ZDF rats followingEA ST36 or non-acupoint
with or without microinfusion NPLA into GN. Values were mean ± SEM (n = 5). ∗P<. 05 versus control.
latenciesto mechanical, coldand thermalstimuli in ZDFrats
were not altered following EA stimulation of either ST36 or
non-acupoint, as shown in Figure 7.
Figure 8 presents a medullary coronal section summa-
rizing the locations of the GN sites for microdialysis during
these studies.
4.Discussion
We compared the foot withdrawal responses to mechanical,
thermal and cold stimuli in ZDF and LC rats following
EA stimulation of ST36. The relationship between eﬀects of
EA ST36 and NO releases in the GN were examined using
microdialysis, and the eﬀectsofNOonwithdrawal responses
to mechanical, thermal and cold stimuli were observed
following microinfusion of an exogenous NO donor and an
inhibitor of neuronal NO synthesis into the GN. The major
ﬁndings in these studies are (i) The withdrawal latencies
to mechanical, cold and thermal stimuli were signiﬁcantly
reduced in ZDF rats compared with LC rats; (ii) EA ST36
with 10 and 30Hz produced better eﬀects on increases
in withdrawal latencies to mechanical, cold and thermal
stimuli compared to the stimulation with 3 and 60Hz; (iii)
T h eb a s e l i n ed i a l y s a t eN O
−
x concentrations in the GN were
decreased in ZDF rats compared to LC rats; (vi) Dialysate
NO
−
x releases in the GN were markedly increased during
EA ST36 in ZDF rats and moderately enhanced 20–40min
after EA ST36 in LC rats; and (v) EA ST36-induced increases
in withdrawal latencies to mechanical, cold and thermal
stimuli were potentiated by microinfusion of an NO donor
and inhibited by an inhibitor of neuronal NO synthesis
into the GN in ZDF rats. The present study is the ﬁrst
evidence showing that dialysate NO
−
x releases in the GN
were markedly increased during EA ST36 in ZDF rats, while
the gracile NO
−
x releases were moderately enhanced 20–
40min after the EA stimulation in LC rats. Withdrawal
latencies to mechanical, hot and cold stimuli in ZDF rats
and LC rats were signiﬁcantly increased following EA ST36
but were not altered by EA stimulation of non-acupoint.
The results also demonstrate that withdrawal latencies to
mechanical, hot and cold stimuli following EA ST36 were
signiﬁcantly potentiated by microinfusion of SIN1, an NO
donor, intothe GNand inhibited by microinfusion of NPLA,
an inhibitor of neuronal NO synthesis into the nucleus in
ZDF rats. The studies suggest that EA ST36 increases the
release of NO in the GN associated with improvement ofEvidence-Based Complementary and Alternative Medicine 9
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Figure 8: Illustration of veriﬁed the sites of microdialysis in the GN by coronal section of the dorsal medulla. Closed circle indicated the
microdialysis tips in the gracile nucleus.
functional neuropathical changes in ZDF rats, and NO in
the GN contributes to therapeutic eﬀects of acupuncture on
improvement in hyperalgesia and hypersensitivity in sensory
diabetic neuropathy.
Neuropathy is a complication of diabetes mellitus with
variable manifestations, and sensory aneuropathic pain is
a complex, chronic pain state, most often accompanied
by a tissue injury. Type II diabetes, non-insulin-dependent
diabetes mellitus is becoming increasingly prevalent in many
countries and aﬀects90% of diabetic patients. Recentstudies
have shown that pain and pressure thresholds are decreased
in ZDF rats, a model of type II diabetes [6–8, 43]. Nerve
conduction velocity is decreased in ZDF rats [3–5]. Previous
pathological studieshave shown that the large caliber dermal
and small caliber epidermal axons in ZDF rats were lost
[8], and the neuroaxonal dystrophy existed in the ileal
mesenteric nerves of ZDF rats [7]. The present results
support previous studies, which reported that pain and
mechanical tolerance of the foot were decreased in ZDF rats.
Ourstudiesfurther show that decreased withdrawal latencies
to application of mechanical, cold and thermal stimuli in
ZDF rats were enhanced by EA ST36, which suggest that
EA ST36 improves functional neuropathical changes in type
II diabetic rats. Recent studies have demonstrated that high
and low frequency EA eﬀects are likely processed in diﬀerent
central areas [44, 45]. Low-frequency EA activates beta-
endorphin and enkephalin systems, while high frequency EA
activates dynorphin systems [45]. It has been demonstrated
that EA ST36 with 10Hz may be a better frequency to
improve hyperalgesia and hypersensitivity in sensory dia-
betic neuropathy [46]. Our data are consistent with previous
studies and demonstrate that EA ST36 with 10 and 30Hz
produced better therapeutic eﬀects compared to EA with 3
and 60Hz in a neuropathic rat model. The results suggest
that EA ST36 with 10Hz is an optimal frequency to treat
sensory diabetic neuropathy.
GN receives ascending input from primary somatic
sensory aﬀerent ﬁbers and the axons of dorsal horn neurons10 Evidence-Based Complementary and Alternative Medicine
as illustrated in Figure 1.P e r i p h e r a ls o m a t o s e n s o r ya ﬀerents
from the hindlimb project to the GN [19–21] and neurons
in the GN are activated by a single electrical stimulus to the
sciatic nerve [19]. It has been demonstrated that the somato-
topic organization of the GN receives peripheral somatosen-
sory aﬀerents from the hindlimb by electrophysiological
mapping studies and anterograde axons tracing techniques
in various mammals [20–24, 47, 48]. These neurons in the
GN receive somatosensory aﬀerent inputs originating from
nociceptors and projecting to the thalamus [22, 47]. Several
studies have shown that the GN is an integration centre for
cutaneous and visceral information ﬂowing into the thala-
mus, which plays an important role in somatic and visceral
pain processing [22–24]. It has been pointed out that the
activation of somatic aﬀerents and acupuncture stimulation
might modulate pain via somatosympathetic reﬂex [49, 50].
This ﬁnding has been veriﬁed through clinical studies with
patients suﬀering from various kinds of chronic pain includ-
ing diabetic neuropathic pain. Present studies show that EA
ST36increasesNOreleaseintheGN,whichmatchesthetime
interval of improving withdrawal latencies to mechanical,
cold and thermal nociception stimuli. Our result supports
previousstudieswhich reportedthattheGNisanintegration
centre for pain processes, and further demonstrates that NO
is released in the GN following EA stimulation. Enhanced
NO release in the GN is involved with the eﬀects of EA ST36
on improvement in sensory diabetic neuropathy.
Recent studies have demonstrated that NO is involved in
the nociceptive modulation, which contributes to analgesic
mechanisms [51, 52]. Previous studies from this lab have
demonstrated that expression of NO synthase in the GN
is induced by sciatic nerve injury [27] and EA stimulation
of hindlimb acupoints in rats [24–26]. Other investigators
reported that impaired neuronal NO generation in diabetic
rats induced hyperalgesia [30, 31]. The present results show
that NO releases in the GN were markedly increased during
EA ST36 in ZDF rats and moderately increased at 20–
40min after EA ST36 in LC rats. A large amount of NO is
released in the GN immediately following EA stimulation
in ZDF rats as compared with only a moderate release 20–
40min after EA in LC rats. This may reﬂect a somatosensory
hypersensitivity of EA stimuli in neuropathic rats. Since
somatosensory response to needle stimuli is higher in ZDF
rats than that of LC rats, greater aﬀerent inputs resulted in
markedly increased dialysate NO
−
x releases in the GN during
EA ST36 in ZDF rats, but not in LC rats. In addition, the
withdrawal latencies to mechanical, coldand thermal stimuli
were improved by EA ST36 in both ZDF and LC rats. These
withdrawal latencies to EA ST36 were further potentiated
by infusion of an NO donor to mimic NO release and
inhibited by microinfusion of an inhibitor of neuronal NO
synthesis in the GN. The results consistently suggest that NO
release in the GN is up-regulated by EA applied to ST36,
and NO in the nucleus produces an inhibitory modulation
of somatosensory/nociceptive susceptibility.
In summary, these results show that neuropathy occurs
in ZDF rats with hyperalgesia and hypersensitivity to
mechanical, thermal and cold stimuli in the hind foot. The
withdrawal latencies were improved by EA ST36, but not
alteredbyEAnon-point.EAstimulationofST36with 10and
30Hz produced better therapeutic eﬀects compared to EA
with 3and 60Hz.Baseline NOrelease was lowerin theGNof
ZDF diabetic rats compared to that of LC rats. NO release in
theGNwasincreasedfollowingEAST36,andthetherapeutic
responses toEAST36inZDFratswerefurther potentiatedby
the presenceof an NOdonorand inhibited by an inhibitor of
NO synthesis in the GN. We conclude that endogenous NO
r e l e a s ei nt h eG Ni sd e c r e a s e di nZ D Fr a t sw i t hh y p e r a l g e s i a
and hypersensitivity of temperature and pressure. EA ST36-
induced NO release in the GN contributes to its eﬀects on
improvement in sensory neuropathies in type II diabetic
rats.
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